Dr. Hind Medyouf, Group Leader at the Institute for Tumor Biology and Experimental Therapy and the Frankfurt Cancer Institute, has been awarded the prestigious European Molecular Biology Organization (EMBO) Young Investigator Programme (YIP) for the year 2018. She joins an active network of 102 current and 314 past Young Investigators.
About EMBO and the EMBO Young Investigator Programme
EMBO is an organization of leading researchers that promotes excellence in the life sciences. The major goals of the organization are to support talented researchers at all stages of their careers, stimulate the exchange of scientific information, and help build a research environment where scientists can achieve their best work. For more information: http://www.embo.org/about-embo.
Established in 2000, the EMBO Young Investigator Programme (YIP) is a highly competitive scheme that highlights some of the best young group leaders in Europe and associated member countries and facilitates their development into world-class researchers, primarily via networking opportunities with current and former Young Investigators. EMBO Young Investigators also benefit from both financial and practical support, including mentorship by EMBO members and access to core facilities at EMBL, Europe’s flagship laboratory for basic research in Molecular Biology.
About Hind Medyouf
Dr. Medyouf joined the Institute for Tumor Biology and Experimental Therapy in October 2014. Her research is focused on exploring the role of the tumor microenvironment in leukemia and solid cancer metastasis. In particular, the group is investigating the complex cellular interactions and molecular mechanisms by which tumor cells co-opt their surrounding stroma to promote immune escape and therapeutic resistance.
The EMBO Young Investigator Programme will facilitate and further promote Dr. Medyouf’s collaborations with colleagues in the EMBO community, which will be crucial to achieve her research goals. “I am thrilled and honored to join such an outstanding programme. The EMBO YIP brings together some of the best young minds in science across Europe. It helps by providing mentorship, facilitating travel to meetings, collaborations and access to EMBL facilities. This is extremely attractive, as my lab members can also take advantage of many of these benefits. The program simply offers great opportunities for our group”, Dr. Medyouf said about the EMBO award.
Dr. Medyouf’s research program is currently supported by the European Research Council (ERC Starting grant), the German Research Foundation (DFG), the German José Carreras Leukemia Foundation (DJCS), the German Cancer Consortium (DKTK) as well as intramural funding from the Institute for Tumor Biology and Experimental Therapy and the Frankfurt Cancer Institute.